Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-22 4:57 pm Purchase | 2024-04-18 | 13G | Zura Bio Limited ZURA | Deep Track Capital, LP | 6,216,327 9.340% | 2,011,327 (+47.83%) | Filing History |
| 2024-04-12 4:08 pm Purchase | 2024-04-02 | 13G | Guardant Health, Inc. GH | Deep Track Capital, LP | 7,000,000 5.750% | 7,000,000 (New Position) | Filing History |
| 2024-04-05 4:00 pm Purchase | 2024-03-27 | 13G | Avalo Therapeutics, Inc. AVTX | Deep Track Capital, LP | 114,775 9.990% | 114,775 (New Position) | Filing History |
| 2024-03-22 4:31 pm Purchase | 2024-03-14 | 13G | Olema Pharmaceuticals, Inc. OLMA | Deep Track Capital, LP | 3,040,248 5.440% | 3,040,248 (New Position) | Filing History |
| 2024-03-22 4:03 pm Purchase | 2024-03-12 | 13G | Regulus Therapeutics Inc. RGLS | Deep Track Capital, LP | 6,888,424 9.990% | 6,888,424 (New Position) | Filing History |
| 2024-03-22 4:02 pm Purchase | 2024-03-14 | 13G | Cybin Inc. CYBN | Deep Track Capital, LP | 1,529,988 7.650% | 1,529,988 (New Position) | Filing History |
| 2024-03-15 4:08 pm Purchase | 2024-03-07 | 13G | Mind Medicine (MindMed) Inc. MNMD | Deep Track Capital, LP | 6,666,667 9.490% | 6,666,667 (New Position) | Filing History |
| 2024-03-08 4:03 pm Purchase | 2024-02-27 | 13G | Pyxis Oncology, Inc. PYXS | Deep Track Capital, LP | 4,184,100 7.870% | 4,184,100 (New Position) | Filing History |
| 2024-02-23 4:48 pm Purchase | 2024-02-14 | 13G | enGene Holdings Inc. ENGN | Deep Track Capital, LP | 2,250,000 5.210% | 2,250,000 (New Position) | Filing History |
| 2024-02-14 11:33 am Sale | 2023-12-31 | 13G | Vigil Neuroscience, Inc. VIGL | Deep Track Capital, LP | 3,649,726 9.620% | -34,893 (-0.95%) | Filing History |
| 2024-02-14 11:32 am Sale | 2023-12-31 | 13G | 89bio, Inc. ETNB | Deep Track Capital, LP | 2,000,000 2.100% | -2,331,499 (-53.83%) | Filing History |
| 2024-02-14 11:31 am Unchanged | 2023-12-31 | 13G | Ambrx Biopharma Inc. AMAM | Deep Track Capital, LP | 3,710,412 5.880% | 0 (Unchanged) | Filing History |
| 2024-02-14 09:02 am Unchanged | 2023-12-31 | 13G | Zura Bio Limited ZURA | Deep Track Capital, LP | 4,205,000 9.290% | 0 (Unchanged) | Filing History |
| 2024-02-14 09:01 am Purchase | 2023-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Deep Track Capital, LP | 5,378,997 9.900% | 2,066,023 (+62.36%) | Filing History |
| 2024-02-14 08:59 am Sale | 2023-12-31 | 13G | Valneva SE VALN | Deep Track Capital, LP | 7,526,807 5.420% | -2,986,458 (-28.41%) | Filing History |
| 2024-02-14 08:58 am Purchase | 2023-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Deep Track Capital, LP | 7,522,281 9.990% | 2,940,281 (+64.17%) | Filing History |
| 2024-02-14 08:57 am Purchase | 2023-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Deep Track Capital, LP | 6,100,000 9.870% | 2,540,000 (+71.35%) | Filing History |
| 2024-02-14 08:56 am Purchase | 2023-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Deep Track Capital, LP | 2,184,440 6.030% | 1,894,118 (+652.42%) | Filing History |
| 2024-02-14 08:56 am Purchase | 2023-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX | Deep Track Capital, LP | 4,063,676 5.530% | 809,544 (+24.88%) | Filing History |
| 2024-02-14 08:55 am Unchanged | 2023-12-31 | 13G | Silence Therapeutics plc SLN | Deep Track Capital, LP | 5,854,740 5.430% | 0 (Unchanged) | Filing History |